US scientists have designed a new receptor and enhanced bioassay
that is set to advance the drug discovery process for diseases such
as cystic fibrosis and Bartter's syndrome, tracking a drug's
activity inside the cell.
Contract biopharmaceutical manufacturer SynCo Bio Partners has
started construction of two new manufacturing suites at its
facility in Amsterdam, the Netherlands, in a move that builds on
the firm's ability to make microbial...
According to a recent report, the emerging market for protein
microarrays will experience strong growth buoyed on by the
emergence of the technology's ability to detect protein expression
more quickly and easily than traditional...
Two novel technologies, designed to check water supplies for
toxins, is set to provide a new on-site monitoring approach,
enhancing current utility monitoring systems that require water
samples to be sent to laboratories for analysis.
Greenbridge Environmental Control of the UK has introdueced a new
cleaner and disinfectant agent, suitable for commercial scale
applications, that is claimed to be the first non-toxic product of
UK drug delivery company Skyepharma has been forced to raise funds
to carry out trials of its combination drug for asthma and chronic
obstructive pulmonary disease (COPD) after failing to find a
partner for the project.
Celtic Pharma has announced the acquisition of a stake in IDEA - a
biopharma company, which is developing targeted therapeutics based
on novel, Transfersome carriers that can increase drug potency and
diminish harmful side effects.
A patent covering a simple design for a safety syringe, which uses
a vacuum rather than a spring to retract the needle after use and
should be cheaper to manufacture than current products, has been
filed in the US by Maxxon Inc.
DecisionNews Media is seeking a further reporter for its
pharmaceuticals industry news services. Applicants must be
exceptionally bright, ambitious and talented, with experience in
news writing on the pharmaceuticals industry.